Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copanlisib + Gemcitabine + Cisplatin in Advanced Cholangiocarcinoma
NCT02631590Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Jul 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of copanlisib in cholangiocarcinoma (CCA), biliary tract carcinoma (BTC), gallbladder carcinoma, sponsored by Moffitt Cancer Center. Started Jul 2016; status: completed.
02
Drugs
copanlisib
03
Conditions
cholangiocarcinoma (CCA)biliary tract carcinoma (BTC)gallbladder carcinoma
Beyond the preview
Go deeper on NCT02631590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631590.